Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Dyslipidemia
In brief
The objective of this study is * To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood lipids and lipoprotein parameter from baseline after 12 weeks of treatment * To evaluate the safety of PRC-4016 as assessed by adverse events and other safety parameters
Key facts
- Study ID
- NCT01972178
- Run by
- Pronova BioPharma
- People needed
- 113
- Starts
- 2013-11-01
- Expected to finish
- 2014-08-01
- Last updated by the study team
- 2015-10-30
Who can join
Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Type I diabetes or uncontrolled type II diabetes
- Recent cardiovascular or coronary event
- History of pancreatitis
- History or evidence of major and clinically significant diseases that would interfere with the conduct of the study or interpretation of data
- Uncontrolled hypertension
Where it is running
- Medical Affiliated Research Center, Inc. — Huntsville, Alabama, United States
- Terence Hart, MD — Muscle Shoals, Alabama, United States
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- National Research Institute - Wilshire — Los Angeles, California, United States
- Research Across America - Santa Ana — Santa Ana, California, United States
- Encompass Clinical Research — Spring Valley, California, United States
- Jacksonville Impotence Treatment Center — Jacksonville, Florida, United States
- Compass Research East, LLC — Oviedo, Florida, United States
- Progressive Medical Research — Port Orange, Florida, United States
- Meridien Research — St. Petersburg, Florida, United States
- Meridien Research- Tampa — Tampa, Florida, United States
- Evanston Premier Healthcare Research LLC — Evanston, Illinois, United States
- Medisphere Medical Research Center — Evansville, Indiana, United States
- Heartland Research Assoc., LLC — Newton, Kansas, United States
- Louisville Metabolic and Atherosclerosis Research Center (L-MARC) — Louisville, Kentucky, United States
- Troy Internal Medicine, P.C. — Troy, Michigan, United States
- Radiant Research - Edina — Edina, Minnesota, United States
- Peters Medical Research — High Point, North Carolina, United States
- PMG Research of Raleigh, LLC — Raleigh, North Carolina, United States
- Sterling Research Group, Ltd. - Auburn — Cincinnati, Ohio, United States
- Metabolic and Atherosclerosis Research Center — Cincinnati, Ohio, United States
- Columbus Clinical Research, Inc. — Columbus, Ohio, United States
- PSB Research/P. S. Bains, M.S., D.O. — Marion, Ohio, United States
- RAS Health Ltd — Marion, Ohio, United States
- Willamette Valley Clinical Studies — Eugene, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.